- Clinical Pharmacology
- Next »
Eldopaque
CLINICAL PHARMACOLOGY
Eldopaque
Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3,4-dihydroxyphenylalanine (dopa) (Denton, C. et al, 1952) 1 and suppression of other melanocyte metabolic processes (Jimbow, K. et al, 1974) 2.
Exposure to sunlight or ultraviolet light will cause repigmentation which may be prevented by the broad spectrum sunscreen agents contained in Solaquin Forte (Parrish, J. A. et al, 1978) 3.
- Clinical Pharmacology
- Next »
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Skin & Beauty
Get beauty tips and body treatments.
Cellulite Treatment with Heat
Most women over 20 have it and hate it, but the bumpy look of cellulite under the skin isn't easy to erase. But a hot technology may change that. See more WebMD Videos »
